
Oncology Pipeline
Research & Development
Our Pipeline
At Servier Pharmaceuticals, our core business is focused in oncology where we believe that we have a unique opportunity to redefine how cancer is treated. We are committed to finding solutions that will address today's challenges. We aim to understand the needs of our patients at all points of their journey, while ensuring those who can benefit from our products have access to them. Advancing innovation for patients is at the heart of everything we do. Servier has significantly accelerated its investment in hard-to-treat cancers with more than 50% of research and development dedicated to deliver significant advances in areas of high unmet need that may truly move the needle for our patients.
Servier’s pipeline includes many oncology assets at varying stages of clinical development.
Hematological Malignancies
Molecule Area | Primary Indication | Partner | Territory | Phase |
---|
Solid Tumors
Molecule Area | Primary Indication | Partner | Territory | Phase |
---|
Anti-TIM3 combo
|
Solid tumors
|
|
Worldwide
|
Phase 2
|
|
PRIMARY INDICATION Solid tumors
|
PARTNER |
PARTNERWorldwide
|
|||
PRIMARY INDICATION Solid tumors
PARTNERTERRITORYWorldwide
|
|||||
Solid tumors
|
Worldwide
|
||||
Anti-CD73
|
Solid tumors
|
|
Worldwide
|
Phase 2
|
|
PRIMARY INDICATIONSolid tumors
|
PARTNER |
PARTNERWorldwide
|
|||
PRIMARY INDICATIONSolid tumors
PARTNERTERRITORYWorldwide
|
|||||
Solid tumors
|
Worldwide
|
||||
Anti-NKG2A
|
Solid tumors
|
|
Worldwide
|
Phase 2
|
|
PRIMARY INDICATIONSolid tumors
|
PARTNER |
PARTNERWorldwide
|
|||
PRIMARY INDICATIONSolid tumors
PARTNERTERRITORYWorldwide
|
|||||
Solid tumors
|
Worldwide
|
||||
More from Servier
Research & Development
We invest in innovative research and development through our own development or partnerships to best address the unmet needs of patients.
Learn MoreClinical Trials
We strive to have consistent and concise transparency throughout all our clinical trials and research and development for the benefit of our patients.
Learn MoreAbout Us
Servier Pharmaceuticals is a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.
Learn More